Selective Wealth Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Selective Wealth Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15	Closed	–	–	770
2022 Q3	$0	Hold	15	–	–	﹤0.01%	842
2022 Q2	$1K	Hold	15	–	–	﹤0.01%	739
2022 Q1	$1K	Hold	15	–	–	﹤0.01%	703
2021 Q4	$1K	Hold	15	–	–	﹤0.01%	648
2021 Q3	$1K	Hold	15	–	–	﹤0.01%	578
2021 Q2	$1K	Buy	+15	New	+$619	﹤0.01%	493

Other funds holding EGRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SGCIA

Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Selective Wealth Management's EGRX Position: Q4 2022 in Review

Selective Wealth Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2022, closing a stake of 15 shares.

Selective Wealth Management first reported a position in EGRX in Q2 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 152 funds tracked by Wall St. Rank hold EGRX as of Q4 2022.

Selective Wealth Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Selective Wealth Management sold 15 Eagle Pharmaceuticals, Inc. shares in Q4 2022.
Selective Wealth Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2021 and held it in 6 quarters.
Selective Wealth Management's Eagle Pharmaceuticals, Inc. position peaked at $1K in Q2 2022.
152 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2022.

Based on Selective Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.